Strand Life Sciences News Today

Quadria, which is currently raising an $800-million fund to invest in healthcare opportunities across India and Asia, has assets under management of $1.4 billion in India.

These advancements are customised to meet the unique requirements of the Indian population and provide unmatched precision, economy, and efficiency, according to a release by the company.

Shares of Palisade Bio, Inc. (PALI) surged over 37% on Tuesday morning after the company announced a strategic collaboration with Strand Life Sciences to advance the precision medicine approach.

Palisade Bio entered into a collaboration with Strand Life Sciences is aimed at advancing precision medicine for ulcerative colitis (UC) therapy and provides the company access to advanced bioinformatics tools vital for understanding complex disease pathways and predicting responses to PDE4 inhibitors.

Balan Gurumoorthy spoke to indianexpress.com on the impact FSID has had on the deeptech ecosystem in the country, its thematic incubators in geriatric healthcare, and more.

Get latest articles and stories on Business at LatestLY. Bengaluru (Karnataka) [India], February 7: Bengaluru-based startup CrisprBits Private Limited, has developed OmiCrisp, a CRISPR based testing platform for rapid diagnosis and surveillance of SARS-CoV2. The CRISPR based test not only detects the virus, but also distinguishes variants of Omicron lineage from other previously known variants of concern. Business News | CrisprBits' OmiCrisp Tracks Omicron-derived JN.1 Variant in Sewage Sa...

The Indian Institute of Technology-Bombay (IIT-B) has issued a correction regarding the data on crore-plus offers in its placement offices earlier press note. In the first phase of placements, 22 students have secured annual pay packages of Rs 1 crore or more, with three being domestic and 19 international.